Karan, Charles
Columbia University Irving Medical Center · Herbert Irving Comprehensive Cancer Center · Columbia University
6 papers on CoChatORCID 0000-0003-4012-8677
Most cited papers
- Verified
Elucidating Compound Mechanism of Action by Network Perturbation Analysis
Woo, J. H., Shimoni, Y., Yang, W. S., Subramaniam, P., Iyer, A., Nicoletti, P., Rodríguez Martínez, M., López, G., Mattioli, M., Realubit, R., et al. (2015) · Cell
Bioinformatics and Genomic NetworksComputational Drug Discovery Methods
Cited by 351
- Verified
A community computational challenge to predict the activity of pairs of compounds
Community, N.-D., Bansal, M., Yang, J., Karan, C., Menden, M. P., Costello, J. C., Tang, H., Xiao, G., Li, Y., Allen, J., et al. (2014) · Nature Biotechnology
Computational Drug Discovery MethodsGene Regulatory Network Analysis
Cited by 321
- Verified
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Alvarez, M. J., Subramaniam, P. S., Tang, L. H., Grunn, A., Aburi, M., Rieckhof, G., Komissarova, E. V., Hagan, E. A., Bodei, L., Clemons, P. A., et al. (2018) · Nature Genetics
Neuroendocrine Tumor Research AdvancesNeuroblastoma Research and Treatments
Cited by 210
- Verified
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., et al. (2022) · Cell Reports Medicine
Computational Drug Discovery MethodsGene expression and cancer classification
Cited by 68
- Verified
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
Obradovic, A., Ager, C., Turunen, M., Nirschl, T., Khosravi-Maharlooei, M., Iuga, A., Jackson, C. M., Yegnasubramanian, S., Tomassoni, L., Fernandez, E. C., et al. (2023) · Cancer Cell
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 66
- Verified
Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments
Mundi, P. S., Dela Cruz, F. S., Grunn, A., Diolaiti, D., Mauguen, A., Rainey, A. R., Guillan, K. C., Siddiquee, A., You, D., Realubit, R., et al. (2021) · Cancer Discovery
Computational Drug Discovery MethodsCancer Genomics and Diagnostics
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free